These stages roughly correspond to acute tumor regression following Her2 downregulation (PT to D10), early-to-late tumor dormancy (D10 to D28), and tumor cell exit from dormancy and proliferation to yield recurrent tumors (D28 to RT) (Fig. 3A). Here, ERBB2 is linked to neoplasm.